Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06272994 · ClinicalTrials.gov registry record · NA
Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 277
- Enrollment target
NCT06272994 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 277 participants.
The verdict
NCT06272994, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 277 participants
- Enrollment target
Study Summary
This is a single center, pragmatic, randomized clinical trial (pRCT) examining whether reporting the results of a negative rapid PCR back to the provider via a pager alert results in decreased vancomycin utilization for critically ill adults with community-acquired pneumonia when compared with usual care.
Interventions
- DIAGNOSTIC_TEST MRSA Nasal Swab PCR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2024-04-03 |
| Est. Completion | 2025-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06272994
The ClinicalTrials.gov registry entry for NCT06272994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 277 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRSA Nasal Swab PCR is the first listed.
NCT06272994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06272994 about?
NCT06272994 is a clinical study titled "Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin". This is a single center, pragmatic, randomized clinical trial (pRCT) examining whether reporting the results of a negative rapid PCR back to the provider via a pager alert results in decreased vancomycin utilization for critically ill adults with community-acquired pneumonia when compared with usual...
What is the current status of trial NCT06272994?
This trial is currently completed. It is a NA study. The enrollment target is 277 participants. The study started on 2024-04-03. Estimated completion is 2025-02-27.
What interventions are being tested in trial NCT06272994?
The interventions under investigation include: MRSA Nasal Swab PCR (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06272994?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.